Glaucoma Trial, Recruiting NCT06577857 Sponsor: Sanoculis Ltd Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT06577857
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have previously had a specific eye procedure called the MIMS® inferonasal surgery, and that surgery took place no more than 24 months before joining the trial.

Who may not be able to join:

  • There are no specific exclusion criteria listed for this trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8082862666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sanoculis Ltd
Registry
ClinicalTrials.gov
Start date
4 November 2022
Est. completion
30 June 2025

Where this trial is recruiting

Armenia

Primary endpoints

Intraocular Pressure Change (Baseline to 24 months); Intraocular Pressure Change (Baseline to 30 months); Change in Number of Topical Intraocular Pressure Lowering Medications (Baseline to 24 Months); Change in Number of Topical Intraocular Pressure Lowering Medications (Baseline to 30 Months); Surgery Success Rate (24 months); Surgery Success Rate (30 months)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov